Abstract:SDF‐1 is a ligand that plays a critical role in cancer metastases and is secreted in specialized somatic cells in the body. Its chemoattractant properties attract and induce migration of tumor cells located in other tissues in the body to the site in which SDF‐1 is secreted. This attraction and migration of tumor cells allows a new tumor to form at secondary locations within the body. Although the understanding of the function of SDF‐1 being secreted in certain regions of the body is not clear, we seek to understand the binding patterns of this ligand with its chemokine receptors CXCR4 and ACKR3 (also called CXCR7). Chemokine receptors are a subclass of G‐protein coupled receptors, which are multi‐pass transmembrane proteins with 7 TM domains. GPCR activation initiates signaling cascades within the targeted cell. Understanding which signaling pathway is favored in CXCR4 and ACKR3 can help us understand the function of SDF‐1 and the mechanism of secondary tumor formation and development. ACKR3 is considered an atypical receptor as it has been experimentally shown to not couple to Gi/o protein in many cells whereas CXCR4 can couple to either Gi/oprotein or β‐arrestin. ACKR3 strongly binds to SDF‐1 and can control the local levels of SDF‐1 available for binding to CXCR4. Both receptors can couple to β‐arrestins, which are proteins responsible for receptor internalization and potential G‐protein‐independent signaling. To understand the interplay between these two receptors in the context of their interactions with SDF‐1, Gi protein, and β‐arrestin, we have successfully generated structural models of these two receptors in apo form, as heterodimers (bound to only SDF‐1, only Gi protein, or only β‐arrestin), and as heterotrimers (bound to both SDF‐1 and Gi protein, or both SDF‐1 and β‐arrestin). These structural models have been relaxed in their physiological environment using a series of molecular dynamics (MD) simulations. Binding free energy analysis of the heterodimers is beginning to shed light on the signaling differences between the two receptors, what identifies ACKR3 as an atypical receptor, and how it sequesters excess SDF‐1 to modulate CXCR4 signaling.

Is myeloid-derived growth factor a ligand of the sphingosine-1-phosphate receptor 2?

Crystal structure and receptor-interacting residues of MYDGF - a protein mediating ischemic tissue repair

Study of the Activating Effects of Myristoyl-Glycine Modified Peptide Which Derived from S1PR3

Structural Basis for Activation of the Growth Hormone-Releasing Hormone Receptor.

Myeloid-derived growth factor suppresses VSMC dedifferentiation and attenuates postinjury neointimal formation in rats by activating S1PR2 and its downstream signaling

Functional receptor for platelet-derived growth factor in rat embryonic heart-derived myocytes: role of sequestered Ca2+ stores in receptor signaling and antagonism by arginine vasopressin

The S1P 1 receptor-selective agonist CYM-5442 reduces the severity of acute GVHD by inhibiting macrophage recruitment

Edg-1, the G Protein-Coupled Receptor for Sphingosine-1-phosphate, is Essential for Vascular Maturation.

Structural insights into sphingosine 1-phosphate receptor 4 activation

Sphingosine 1-phosphate potentiates human lung fibroblast chemotaxis through the S1P2 receptor.

Sphingosine 1-phosphate (S1P)/S1P receptors are involved in human liver fibrosis by action on hepatic myofibroblasts motility

Ligands Binding to Cell Surface Ganglioside GD2 Cause Src-Dependent Activation of N-Methyl-D-Aspartate Receptor Signaling and Changes in Cellular Morphology

Sphingosine 1-Phosphate Stimulates Cell Migration through a Gi-coupled Cell Surface Receptor

An overview of sphingosine‐1‐phosphate receptor 2: Structure, biological function, and small‐molecule modulators

Myeloid-derived growth factor in diseases: structure, function and mechanisms

Sphingosine 1-Phosphate Receptor 5 (S1P5) Deficiency Promotes Proliferation and Immortalization of Mouse Embryonic Fibroblasts

Glycosylation-Independent Binding to Extracellular Domains 11-13 of Mannose-6-Phosphate/Insulin-Like Growth Factor-2 Receptor Mediates the Effects of Soluble Creg on the Phenotypic Modulation of Vascular Smooth Muscle Cells

The relationship between sphingosine-1-phosphate receptor 2 and epidermal growth factor in migration and invasion of oral squamous cell carcinoma

The Role of SDF‐1 in Signaling Differences Between CXCR4 and Atypical ACKR3 Chemokine Receptors

Involvement of sphingosine 1-phosphate in nerve growth factor-mediated neuronal survival and differentiation

Structural Basis of Sphingosine-1-phosphate Receptor 1 Activation and Biased Agonism